Population characteristics of children with short stature and construction of a predictive model for growth hormone treatment efficacy
By
Chuanwei Ban
Juan Wang
Qian Zeng
Ping Liu
Xin Lv
July 7, 2026
Clinical Scorecard: Demographic Analysis of Pediatric Short Stature and Development of a Predictive Model for Growth Hormone Therapy Effectiveness
At a Glance
Category Detail
Condition Short Stature Key Mechanisms Growth hormone treatment improves growth velocity. Target Population Children diagnosed with short stature. Care Setting Pediatric clinical practice.
Key Highlights
293 children included after exclusions. Growth hormone intervention group showed significantly higher growth velocity than nutritional support group. Duration of growth hormone therapy is a significant predictor of treatment efficacy. A predictive nomogram model was developed and validated. 3.2% prevalence of short stature in children reported in China. Guideline-Based Recommendations
Diagnosis
Short stature defined as height below -2 standard deviations or below the 3rd percentile. Management
Individualized treatment plans including watchful waiting, nutritional support, and growth hormone therapy. Monitoring & Follow-up
Annualized growth velocity should be monitored to assess treatment efficacy. Risks
Long-term growth hormone treatment imposes substantial economic burden. Patient & Prescribing Data
Pediatric patients with short stature.
Growth hormone therapy shows consistent benefits across different causes of short stature.
Clinical Best Practices
Utilize a predictive model for individualized dynamic efficacy assessment during treatment. Counsel parents thoroughly regarding treatment options. Related Resources & Content
